ImmPACT Bio | ApexOnco - Clinical Trials news and analysis

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Deals

25 October 2024

Regulatory

29 November 2023

But the FDA’s investigation looks like worse news for autoimmune disease than oncology.

Recent Quick take